News from us and our partners

Tags

Topics

0 results

News
5 June, 2023
Amolyt Pharma announces initiation of phase 1 clinical trial of peptide growth hormone receptor antagonist (GHRA), AZP-3813, for Acromegaly
News
1 June, 2023
Gradient Denervation Technologies enrolls initial patient in first-in-human study of pulmonary artery denervation technology
News
31 May, 2023
BrightHeart announces €2 million in seed financing from Sofinnova Partners to improve the detection of fetal heart abnormalities
News
23 May, 2023
TISSIUM Raises €50M in Series D funding to finance its commercial launch and platform extension
News
18 May, 2023
F2G moves UK headquarters to MediaCity in Manchester
News
17 May, 2023
Moon Surgical appoints Fred Moll, MD, as Board Chair and raises additional $55.4 million in new funding with leading investors Sofinnova Partners and NVIDIA
News
12 May, 2023
PinCell's studies open up new indications for lead candidate
News
10 May, 2023
Sustainable performance fibers company Werewool raises $3.7 million led by Material Impact and Sofinnova Partners
News
9 May, 2023
Alia Therapeutics appoints Adel Nada as Independent Board Director
News
4 May, 2023
Alia Therapeutics names Letizia Goretti as Chief Executive Officer
News
4 May, 2023
PinCell announces 2 successful in-vivo studies for breakthrough skin disease therapy
News
3 May, 2023
Moon Surgical appoints Anne Renevot as Chief Financial Officer
News
2 May, 2023
Amolyt Pharma announces Phase 3 clinical trial of Eneboparatide for the treatment of hypoparathyroidism following positive end of Phase 2 Meeting with FDA
News
1 May, 2023
COMET opens first arabinoxylan dietary fiber facility
News
1 May, 2023
Inspirna appoints Dr. Usman “Oz” Azam, M.D., as new Chief Executive Officer
News
24 April, 2023
Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture

Amolyt Pharma announces initiation of phase 1 clinical trial of peptide growth hormone receptor antagonist (GHRA), AZP-3813, for Acromegaly

Gradient Denervation Technologies enrolls initial patient in first-in-human study of pulmonary artery denervation technology

BrightHeart announces €2 million in seed financing from Sofinnova Partners to improve the detection of fetal heart abnormalities

TISSIUM Raises €50M in Series D funding to finance its commercial launch and platform extension

F2G moves UK headquarters to MediaCity in Manchester

Moon Surgical appoints Fred Moll, MD, as Board Chair and raises additional $55.4 million in new funding with leading investors Sofinnova Partners and NVIDIA

PinCell's studies open up new indications for lead candidate

Sustainable performance fibers company Werewool raises $3.7 million led by Material Impact and Sofinnova Partners

Alia Therapeutics appoints Adel Nada as Independent Board Director

Alia Therapeutics names Letizia Goretti as Chief Executive Officer

PinCell announces 2 successful in-vivo studies for breakthrough skin disease therapy

Moon Surgical appoints Anne Renevot as Chief Financial Officer

Amolyt Pharma announces Phase 3 clinical trial of Eneboparatide for the treatment of hypoparathyroidism following positive end of Phase 2 Meeting with FDA

COMET opens first arabinoxylan dietary fiber facility

Inspirna appoints Dr. Usman “Oz” Azam, M.D., as new Chief Executive Officer

Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture